Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-12-23
DOI
https://doi.org/10.1111/jdv.70284
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies

Lee Yt, Tsai Ling Ting
Journal of the European Academy of Dermatology and Venereology
Cancer Immunotherapy and Biomarkers
article

Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies

Lee Yt, Tsai Ling Ting
article en

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and Venereology
Chung Shan Medical University Hospital (TW), Chung Shan Medical University (TW)
Peace, Justice and strong institutions
Openalex Percentile: Top 31%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies — Lee Yt, Tsai Ling Ting · Journal of the European Academy of Dermatology and Venereology (2025) | TGRS Research Map | TGRS